The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (<scp>START</scp>) bone mineral density substudy

Andrew Carr(UNSW Sydney), Anchalee Avihingsanon(Chulalongkorn University), Sharlaa Badal‐Faesen(University of the Witwatersrand), Sanjay Pujari, Kristine E. Ensrud(University of Minnesota), David White, Birgit Grund(University of Minnesota), Jennifer Hoy(The Alfred Hospital), NW Engen(University of Minnesota), Alberto La Rosa(Asociación Civil Impacta Salud y Educación), JI Bernadino(Hospital Universitario La Paz), Vicente Estrada(Instituto de Salud Carlos III), AV Schwartz(University of California, San Francisco)
HIV Medicine
October 23, 2019
10.1111/hiv.12796
Cited by 19

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
|BMC Medicine|2016|904
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728